LABEEUW; Olivier

Patent Applications and Registrations

Patent applications and USPTO patent grants for LABEEUW; Olivier.The latest application filed is for "benzimidazole derivatives as dual histamine h1 and histamine h4 receptor ligands".

Company Profile

2.7.9

LABEEUW; Olivier - FOUGERES FR
Labeeuw; Olivier - Rennes FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Benzimidazole Derivatives As Dual Histamine H1 And Histamine H4 Receptor Ligands App 20220281839 - BERREBI-BERTRAND; Isabelle ; et al.	2022-09-08
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands Grant 11,306,069 - Berrebi-Bertrand , et al. April 19, 2	2022-04-19
Therapeutical use of H3-ligands Grant 11,179,329 - Lecomte , et al. November 23, 2	2021-11-23
Benzimidazole Derivatives As Dual Histamine H1 And Histamine H4 Receptor Ligands App 20190144421 - BERREBI-BERTRAND; Isabelle ; et al.	2019-05-16
6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands Grant 9,255,101 - Berrebi-Bertrand , et al. February 9, 2	2016-02-09
Benzazole derivatives as histamine H4 receptor ligands Grant 9,029,357 - Berrebi-Bertrand , et al. May 12, 2	2015-05-12
Benzazole Derivatives as Histamine H4 Receptor Ligands App 20150004181 - BERREBI-BERTRAND; Isabelle ; et al.	2015-01-01
Benzazole derivatives as histamine H4 receptor ligands Grant 8,802,664 - Berrebi-Bertrand , et al. August 12, 2	2014-08-12
New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands App 20130324506 - BERREBI-BERTRAND; Isabelle ; et al.	2013-12-05
Novel (aza)Benzhydryl Ether Derivatives, Their Process of Preparation and Their Use as H4-Receptor Ligands for Therapeutical Applications App 20130324507 - BERREBI-BERTRAND; Isabelle ; et al.	2013-12-05
Benzazole Derivatives as Histamine H4 Receptor Ligands App 20130231329 - Berrebi-Bertrand; Isabelle ; et al.	2013-09-05
Novel Pharmaceutically Acceptable Salts Of 4-(1h-imidazol-4-ylmethyl)pyridine And Their Therapeutical Uses App 20120129892 - Capet; Marc ; et al.	2012-05-24
Histamine H3-receptor ligands and their therapeutic applications Grant 8,076,329 - Bertrand , et al. December 13, 2	2011-12-13
Novel Histamine H3-receptor Ligands And Their Therapeutic Applications App 20090111808 - Bertrand; Isabelle ; et al.	2009-04-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.